Y Intercept (Hong Kong) LTD Taysha Gene Therapies, Inc. Transaction History
Y Intercept (Hong Kong) LTD
- $1.37 Billion
- Q1 2025
A detailed history of Y Intercept (Hong Kong) LTD transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 83,864 shares of TSHA stock, worth $227,271. This represents 0.01% of its overall portfolio holdings.
Number of Shares
83,864Holding current value
$227,271% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding TSHA
# of Institutions
127Shares Held
151MCall Options Held
70KPut Options Held
4.7K-
Avoro Capital Advisors LLC New York, NY20MShares$54.2 Million0.45% of portfolio
-
Rtw Investments, LP New York, NY18.8MShares$50.9 Million0.43% of portfolio
-
Morgan Stanley New York, NY16.8MShares$45.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$31.8 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA10.9MShares$29.5 Million0.31% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $131M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...